Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Xiaoyan Pan and Gengfu Xiao.
Xiaoyan Pan
Connection Strength
2.108
Gengfu Xiao
  1. Immunoglobulin fragment F(ab')2 against RBD potently neutralizes SARS-CoV-2 in vitro. Antiviral Res. 2020 10; 182:104868.
    View in: PubMed
    Score: 0.892
  2. Novel neutralizing monoclonal antibodies against Junin virus. Antiviral Res. 2018 08; 156:21-28.
    View in: PubMed
    Score: 0.770
  3. Comprehensive Interactome Analysis Reveals that STT3B Is Required for N-Glycosylation of Lassa Virus Glycoprotein. J Virol. 2019 12 01; 93(23).
    View in: PubMed
    Score: 0.213
  4. SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target. Cell Res. 2021 08; 31(8):847-860.
    View in: PubMed
    Score: 0.059
  5. High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors. Protein Cell. 2021 11; 12(11):877-888.
    View in: PubMed
    Score: 0.059
  6. Drug Repurposing of Itraconazole and Estradiol Benzoate against COVID-19 by Blocking SARS-CoV-2 Spike Protein-Mediated Membrane Fusion. Adv Ther (Weinh). 2021 Feb 22; 2000224.
    View in: PubMed
    Score: 0.058
  7. Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein. Signal Transduct Target Ther. 2020 10 06; 5(1):220.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.